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ABSTRACT Glioblastoma, the most malignant form of brain cancer, is responsible for 23% of primary brain tumors and has
extremely poor outcome. Confounding the clinical management of glioblastomas is the extreme local invasiveness of these cancer
cells. The mechanisms that govern invasion are poorly understood. To gain insight into glioblastoma invasion, we conducted
experiments on the patterns of growth and dispersion of U87 glioblastoma tumor spheroids in a three-dimensional collagen gel.
We studied two different cell lines, one with a mutation to the EGFR (U87DEGFR) that is associated with increased malignancy,
and one with an endogenous (wild-type) receptor (U87WT). We developed a continuum mathematical model of the dispersion
behaviors with the aim of identifying and characterizing discrete cellular mechanisms underlying invasive cell motility. The mathe-
matical model quantitatively reproduces the experimental data, and indicates that the U87WT invasive cells have a stronger
directional motility bias away from the spheroid center as well as a faster rate of cell shedding compared to the U87DEGFR
cells. The model suggests that differences in tumor cell dispersion may be due to differences in the chemical factors produced
by cells, differences in how the two cell lines remodel the gel, or different cell-cell adhesion characteristics.
INTRODUCTION
The outcome for patients with highly malignant brain tumors
is extremely poor. Glioblastoma Multiforme (GBM), the
most malignant form of brain cancer, is responsible for 23%
of primary brain tumors and has a median survival time of
,15 months (1). One factor that makes GBM so difﬁcult to
treat is its high invasiveness enabling tumor cells to disperse
from the main tumor mass into the surrounding normal brain,
so that dispersed glioma cells are out of reach of surgery,
radiation, and chemotherapy. The invasive cells present a
different phenotype than the cells of the main tumor mass.
Factors responsible for conversion from a relatively station-
ary to a migratory/invasive phenotype are not completely
understood. However, several mechanisms such as chemo-
kinesis (undirected motility), chemotaxis (directed motility
along chemical gradients), haptotaxis, cell-cell adhesion, and
cell-cell signaling, upregulation of pro-survival pathways, and
microenvironmental cues are involved in that process (1–4).
A genetic aberration that occurs in 40–60% of GBMs
results in the ampliﬁcation or overexpression of the Epider-
mal Growth Factor Receptor gene (EGFR), which has been
related to poor prognosis in glioblastoma patients (5). The
most common mutation (DEGFR) leads to an in-frame
deletion resulting in a constitutively active receptor, deﬁcient
in the negative feedback mechanism normally triggered by
binding of its ligand (6). It has been shown that cells with
DEGFR proliferate slightly faster (7) and undergo less
apoptosis both in serum-free in vitro conditions and in vivo
than cells with the wild-type receptor, EGFRwt (8).
Lal et al. (9) showed that genes for matrix-degrading en-
zymes were upregulated in DEGFR cells both in vivo and in
vitro. Chicoine and Silbergeld showed that increased malig-
nancy in vivo is typically associated with increased motility
in vitro (10). The extent to which each of these discreet
functions is related to tumor cell invasiveness is unclear. The
goal of this work is to better understand the mechanisms that
govern invasive cell behavior. We speciﬁcally focus on the
changes in the invasive phenotype caused by the DEGFR
mutation. We present new results from experiments where
tumor spheroids are grown in three-dimensional collagen
gels. We then describe a continuum mathematical model that
allows us to quantitatively interpret the data. Fitting the model
to the experimental data indicates that, when compared to the
U87DEGFR cell line, glioma cells with EGFRwt receptor
invade in a more biased manner, away from the tumor spher-
oid and are shed from the spheroid at a greater rate, sug-
gesting lower cell-cell adhesion.
EXPERIMENTAL BACKGROUND
Cell culture conditions
Human astrocytoma cell line U87 expressing EGFRwt (here-
after U87WT) (American Type Culture Collection, Manassas,
VA) and a sub-line stably transfected with the truncated form
of EGFR (U87DEGFR) (7,8,11) were maintained in mini-
mum essential medium (Invitrogen, Carlsbad, CA) sup-
plemented with 10% heat-inactivated fetal bovine serum
Submitted July 21, 2006, and accepted for publication September 21, 2006.
Address reprint requests to A. M. Stein, Dept. of Mathematics, University of
Michigan, 2074 East Hall, 525 Church St., Ann Arbor, MI 48109. E-mail:
amstein@umich.edu.
 2007 by the Biophysical Society
0006-3495/07/01/356/10 $2.00 doi: 10.1529/biophysj.106.093468
356 Biophysical Journal Volume 92 January 2007 356–365
(Hyclone Laboratories, Logan, UT) in a 37C, 5% CO2
atmosphere at constant humidity.
Three-dimensional invasion assay
Spontaneously formed multicellular spheroids derived from
U87WT and U87DEGFR glioma cell lines were implanted
into self-assembling collagen-I gels (2.6 mg/ml; Vitrogen,
Cohesion, Palo Alto, CA) supplemented with minimal es-
sential media and 2% fetal bovine serum and cultured for
seven days under standard cell culture conditions (12). Digi-
tal photomicrographs of the midplane of spheroids were taken
daily (253 total magniﬁcation, Zeiss Axiovert 130, Carl Zeiss,
Echingen, Germany). To ﬁnd the radius of invasion in an
image I, we calculated the magnitude of the gradient of the
image, G ¼ j=Ij, and averaged it over the azimuthal angle to
ﬁnd GðrÞ. We then deﬁned the radius of invasion to be the
distance farthest from the center where GðrÞ was half its
maximum. This calculation automatically circumscribes the
dispersing glioma cells with high precision and accuracy,
while also agreeing with manual assessment of the area
occupied by dispersing cells. The radius of the compact
cellular core of each spheroid was scored by ﬁrst scaling a
120 mm 3 120 mm gray-scale image centered on the tumor
spheroid, such that the darkest pixel had value 0 and the
lightest pixel had value 1. The core was identiﬁed as the set
of pixels with an intensity of ,0.12. This particular value
was chosen because it is restricted to a region of the
dispersing spheroid where cell (pixel) density is high, but
falling rapidly; this measure also approached what an ex-
perimenter would identify by eye as the core boundary.
Typical results are shown in Fig. 1.
Histology
Collagen gels containing glioma spheroids were ﬁxed in
10% neutral buffered formalin on days 3, 5, and 7. Fixed gels
were parafﬁn-embedded using routine histological protocols
then microtome-sectioned at 5-mm thickness. For each time
point, slides were stained with hematoxylin and eosin for
morphological evaluation. Immunohistochemistry of Ki67
antigen was performed on formalin-ﬁxed-parafﬁn-embedded
(FFPE) spheroid sections (13). Brieﬂy, FFPE slides were
baked at 65C for 2 h, deparafﬁnized in xylenes, and then
rehydrated in graded alcohol series followed by water.
Antigen retrieval was performed in 10 mM sodium citrate
buffer, pH 6.5 in a pressure cooker at 90C for 1 min.
Endogenous peroxidases were quenched in 3% hydrogen
peroxide solution in Tris-buffered saline (TBS) for 10 min.
The slides were blocked for 15 min in TBS containing 0.1%
Triton X-100 with 3% normal horse serum provided in the
Vectastain ABC Elite Mouse IgG kit (Vector Laboratories,
Burlingame, CA). Primary anti-Ki67 antibody (#M7240,
Dako, Santa Barbara, CA) was diluted 1:100 and incubated
for 1 h at room temperature. Slides were rinsed for 5 min in
TBS Tween (TBST) and horse anti-mouse IgG was added
according to manufacturer instructions. Slides were rinsed
for 5 min in TBST, then ABC reagent was added according
to manufacturer instructions. Slides were rinsed again for
5 min in TBST and DAB peroxidase substrate (Sigma, St.
Louis, MO) was added for 2 min. Lastly, slides were rinsed
in water, counterstained withMayer’s hematoxylin, dehydrated
in an alcohol series followed by xylene, and coverslipped.
The number of cells exhibiting positive staining for Ki67
was expressed as percentage of total number of cells
(Proliferative-index) in the core and rim areas. The slices
from day 3 adequately captured cells in the invasive zone.
The nuclei of the images were identiﬁed by a particle track-
ing method previously described by Crocker and Grier (14)
and used to estimate the cell density as a function of radial
distance from the spheroid center.
Experimental data
Images taken from the experiments are shown in Fig. 1.
Averaged measurements of the core and invasive radii from
FIGURE 1 The difference in invasion between U87WT and U87DEGFR.
The tumor spheroid images (3 mm 3 3 mm) were taken from the
experiments. The inner and outer circles indicate the core boundary and
invasive rim, respectively.
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16 different experiments are shown in Fig. 2. There are two
major features to note in the ﬁgure. First, the U87WT cells
are more invasive than U87DEGFR. This was unexpected,
since the mutant cell line was described to be more malignant
in animal models (6); see Fig. 2 b. Second, the radius of the
expanding U87WT spheroids decreases during the initial day
in the gel, but subsequently increases at a rate ;27 mm/day;
see Fig. 2 b. The decrease in the radius of U87WT spheroids
on day 1 occurred in all 16 experiments. The radius of spher-
oids from U87DEGFR cells did not show an initial decrease,
but expanded at a steady rate of 27 mm/day. Enumeration of
cells in the hematoxyln and eosin-stained FFPE sections of
U87WT spheroids at days 3, 5, and 7 revealed 343, 709, and
811 cells in the core area per 203 objective ﬁeld, while the
core area of U87DEGFR spheroids contained only 132 cells
on day 7. The differential cell density per ﬁeld indicates
lower cell compaction (possibly slower growth) of the
U87DEGFR cells in spheroid conditions compared to
U87WT. The Ki67 index of U87WT spheroids on day 5
was 22% in the core region compared to 6% in the invasive
edge, suggesting that dispersing cells at the spheroid’s edge
have deferred proliferation. These data demonstrate pro-
nounced differences between the cell lines relative to their
interaction with a three-dimensional collagen matrix.
We could account for these features of glioma spheroid
expansion in two different ways. The simplest explanation is
that the EGFR-wild type cells are inherently more motile
leading to a very high initial invasion rate on day 1 with
considerable egress of cells out of the spheroid. This would
result in a reduction of the compacted spheroid diameter. The
burst of motility might be described by random motility or
directed motility, or some combination of the two, which
might differ for the two cell lines. Alternatively, the system
could be dominated by cell-cell adhesion phenomenon in the
spheroid. The U87WT and U87DEGFR cells might be
equally motile in the absence of cell-cell connections, but if
cell-cell adhesion is stronger in the mutant cells, the mutant
cells would be less dispersive because they would be
released at a slower rate from the surface of the spheroid.
In the mathematical model, we assume that the cell lines
differ in their motility, shedding rates, and proliferation.
Development of mathematical models of cell dispersion
from solid tumor masses is needed to lay a foundation that
will allow inclusion of more complex data such as gene-
expression proﬁling, phosphoproteomics, cell-matrix inter-
actions, signal transduction activation, cell traction forces in
the matrix, etc.
MATHEMATICAL MODELING
In this section, we report attempts to assess the relative
importance of the various biological processes underlying
dispersion from multicellular spheroids using mathematical
modeling of the patterns of invasion discerned from the
images. As will be seen, the model affords quantitative
FIGURE 2 Experimental results. Core radius is the radius of the central
spheroid. Invasive radius denotes the outer rim of the invasive region. (a)
U87WT spheroids are more invasive than U87DEGFR spheroids. (b) The
cores of the U87WT and U87DEGFR spheroids grow at approximately the
same speed after day 1, but the U87WT core decreases in size in the ﬁrst day
in the collagen gel. (c) A log plot of cell density on day 3 as a function of
position. The dashed line on the left of each plot denotes the core boundary
and the dashed line to the right denotes the boundary of invasion.
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comparisons between theory and experiment so that various
hypotheses of the mechanisms governing invasive cell
motility can be tested.
There are several mathematical models in the literature for
cell invasion (15–17). For the speciﬁc case of GBM, see the
literature (18–25). Frieboes et al. (26) model GBM growth
for in vitro experiments. Their model is designed to explain
the irregular shape of the tumor core (not seen in these
experiments) while the model presented here is designed to
describe the cells that leave the main tumor mass and invade
the collagen gel. A design that is closest to our approach is
reported by Swanson et al. (27). As will be discussed below,
we think that Swanson et al. (27) must be generalized to
account for differences between invasive and proliferative
cells. Our work is based on new experimental data and
describes the behavior of invasive cells in a way that can be
quantitatively compared to the experimental measurements.
Single population model for core and invasive
cell behavior
In the model of Swanson et al. (27), tumor growth is
described by a reaction-diffusion equation:
@u=@t ¼ D=2u1 guð1 u=umaxÞ: (1)
This equation describes cells of concentration u(r, t) that
move along undirected, random paths as a function of
position and time. Cells throughout the tumor are assumed to
proliferate at a constant rate g until they reach a limiting
density, umax. The value D is the diffusion (undirected
motion); the larger D becomes, the more motile the cells.
This model assumes spherical symmetry of the multicellular
tumor spheroid. The reaction-diffusion model has been used
with some success to describe how a tumor responds to che-
motherapy and why surgical removal of GBM is usually not
effective (27).
This model is only applicable for tumors that are .1 mm3
(27), whereas the tumor spheroids in the current experiments
have an initial volume of 0.07 mm3. The reason the single-
population reaction-diffusion model fails for small tumors is
that for small spheroids the cell populations of core and rim
manifest different proliferative and dispersive behaviors as a
consequence of being in two distinct regions of the multi-
cellular system: there is a central core and an invasive rim.
The central core contains cells that proliferate rapidly but move
slowly; the invasive rim contains cells that proliferate slowly
but are highly motile (i.e., the go-or-grow hypothesis (2)).
The need to generalize Eq. 1 becomes evident when we
attempt to model our experiments. We can either capture the
behavior of the core or the invasive region, but not both. If
we choose a D  104 cm2/day, we can ﬁt the invasive radii
plots in Fig. 2 b, but the cells in the core also rapidly diffuse
throughout the environment and within a few days, the
central core would almost disappear. If, on the other hand,
we choose a smaller D, we can accurately model the core
growth, but the invasive cells would move far too slowly.
With a two-population model, we can simultaneously model
both the core and the invasive region. This reﬂects the
biology of the dispersive multicellular spheroid: the invasive
cells are a different phenotype (2,3) from the core cells, and
have different motility and proliferation rates.
Modeling the difference in behavior of the core
and invasive cells
To account for the different behaviors of the tumor spheroid
and the invasive cells, we model the tumor core as a sphere
increasing in radius at a constant rate, vc, and shedding
invasive cells at a rate, s. To motivate such a model, we note
that multicellular tumor spheroids, when grown in soft agar
or methylcellulose, ﬁrst grow exponentially, then linearly,
and ﬁnally stop growing altogether (28). Linear growth
typically occurs for spheroids that are between 0.1 mm and
0.5 mm in radius, as in our experiment (see Fig. 2 b). It has
also been observed that spheroids cultured in spinner ﬂasks
(in liquid suspension) shed cells at a constant rate (29). Since
the spheroids in these experiments are grown in a ﬂuid, the
cells that are shed are quickly whisked away from the neigh-
borhood of the spheroid. In the collagen matrix, however, the
cells that are shed are precisely the invasive cells in which we
are interested.
The invasive cells, ui(r, t), diffuse and proliferate as in
Eq. 1. In addition, the invasive cells are biased to move away
from the center of the tumor spheroid at an average speed, vi.
It has been observed that invasive cells may follow directed
paths away from the tumor spheroid (30). The cause of this
bias is not known. It may be due to attraction toward nutri-
ents in the environment, repulsion from waste products pro-
duced by the spheroid, or a realignment of the collagen gel as
the cells move. One purpose of this work is to determine
whether such a velocity bias is present in these experiments.
The equation for the evolution of the invasive cell
population, ui(r, t) is given below.
@ui
@t
¼ D=2ui  vi=r  ui1 sdðr  RðtÞÞ1 guið1 ui=umaxÞ:
(2)
The behavior of the invasive cells can be described by four
parameters: fD, vi, s, gg. Invasive cells are introduced into
the population through shedding from the core surface, s, and
proliferation, g. Cell motility is modeled as having an
undirected component, D, and a radially biased component,
vi. Similar models have been used for describing the motility
of macrophages and endothelial cells (31,32). In the above
equation, d is the Dirac delta function, r is the spatial
coordinate for the radial distance from the tumor center, and
R(t) is the radius of the core at time t. We take the core radius
to be given by R(t) ¼ R0 1 vct, where R0 is the initial tumor
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radius, and vc is the rate at which the core increases in radius.
It should be noted that the model allows for invasive cells to
be reabsorbed by the core, as observed in some experiments.
At time t ¼ 0, there are no invasive cells present, and
ui(r, 0) ¼ 0. The boundary condition at r ¼ 0 is symmetric,
and far from the tumor, ui(r, t)¼ 0. Equation 2 was simulated
using operator splitting. A Crank-Nicholson method was
used for diffusion, upwind differencing was used for advection,
and a ﬁrst-order forward difference was used for proliferation
and cell shedding.
Parameter estimation
The following parameters were ﬁxed. The initial tumor
radius, measured directly from the images, was R0 ¼ 250
mm. The core growth rate, obtained from a least-squares ﬁt
of Fig. 2 b, starting from day 1 gave vc ¼ 27 mm/h. To
estimate umax, we assume that the volume of a typical cell is
1200 mm3, as it is for EMT6/Ro tumor cells (33). Assuming
that half the volume of the spheroid is made up of tumor
cells, the maximum density is umax ¼ 4.2 3 108 cells/cm3.
To quantitatively compare our model to Fig. 2 a, we need
to choose a cutoff threshold for u(r, t), at which to deﬁne the
invasive boundary of a continuous density function. We
chose the threshold using the density plots shown in Fig. 2 c,
and noting where the invasive boundary, indicated by the
right-hand dashed line, intersects the density plot. The
threshold was 1 3 107 cells/cm3 for U87WT and 2.5 3 106
cells/cm3 for U87DEGFR. We did not use the same threshold
for both cell lines because this was not what was seen
experimentally. A visual inspection of Fig. 1 supports this
difference, where there appear to be more invasive cells at
the boundary of the U87WT than at the boundary of the
U87DEGFR spheroid.
The parameters for describing invasive cell behavior, fD,
vi, s, gg, are optimized to ﬁt the data. While we do not know
their exact values, we have identiﬁed reasonable ranges for
these parameters. The results in Hegedus et al. (34) and the
data of Demuth et al. (35) suggest a D between 13 105 and
23 104 cm2/day. It should be noted that these studies were
for cells moving on a two-dimensional substrate. To our
knowledge, there have been no direct estimates for D in three
dimensions. It has been observed that invasive cells close to
the tumor spheroid move at a velocity 0.05 cm/day away
from the spheroid center (30). Thus, we assume vi is between
0 and 0.1 cm/day. The shedding rate for EMT6/Ro spheroids
grown in spinner ﬂasks was 218 cells/(mm2 min) or 5 3 105
cells/(cm2 day). The collagen matrix has the potential to
enhance shedding, by providing the cells a substrate on
which to move, but it also has the potential to inhibit
shedding if the cells have difﬁculty moving through the
collagen mesh. We assume that s is between 1 3 104 and
1 3 107 cells/(cm2 day). The cell doubling time has been
seen to be as fast as 20 h at the spheroid core (12), giving a g
as large as 0.83/day. However, since GBM cells can be either
highly proliferative or highly motile, but not both (2), g for
the invasive cells is signiﬁcantly lower. We assume that g is
between 0 and 0.3/day. The bounds are summarized in Table 1.
Parameter optimization
We ﬁt the model to the data by choosing fD, vi, s, gg to
minimize the x2 error function:
x
2ðD; vi; s; gÞ ¼ 1










Here, Ri(t) is the invasive radius, and ui(r, t3) is the cell
density at day 3, both measured from experiment. The
variables R˜iðtÞ and u˜iðr; t3Þ, represent the corresponding
quantities that were generated by the model for a particular
choice of parameters fD, vi, s, gg. The parameters, sR and
su, denote the standard deviation of the measurement of the
invasive radius and cell density at day 3, respectively. The
total number of data points, N, is 33, and the number of
ﬁtting parameters, n, is 4. We consider a x2 error ,1 to be a
good ﬁt to the model. This corresponds to an average error of
a mean ;1 6 SD at each data point. The error function was
minimized with a Sequential Quadratic Programming
method, using the fmincon.m optimization function in
MatLab (The MathWorks, Natick, MA).
RESULTS
We ﬁrst tested whether invasion was an undirected process
(vi ¼ 0) for both cell lines, such that the difference between
the two could be explained entirely by different D-values.
The parameters were optimized to ﬁt the data for both cell
lines and the results are shown in Fig. 3, along with a list of
parameters. The U87DEGFR cell line can adequately be
described by undirected invasion, with a x2 error of 0.1. The
best ﬁt to the U87WT model, however, is quite poor, with an
error of 3.1. The error could be reduced by a factor of 10 by







Cell line LB UB LB UB LB UB
D 3 104 (cm2/day) 0.1 2.0 0.1 2.0 0.1 2.0
vi (cm/day) 0 0.10 0 0.015 0.010 0.10
s 3 106 cells/(cm2 day) 0.01 10 0.17 0.69 0.70 6.5
g (1/day) 0 0.30 0 0.30 .04 0.30
The model has led to tighter estimates (in bold) for vi, s, and g than were
previously known. LB indicates a lower bound and UB indicates an upper
bound. The choice of the original bounds is explained in Parameter
Estimation and Parameter Optimization. The revised bounds were based on
Fig. 6. The bounds were chosen to be where the x2 error was ,1.
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loosening the restrictions on D and allowing D ¼ 2 3 103
cm2/day, which is 10 times larger than what has been seen
in other experiments. Thus the model indicates either that
the primary mechanism of motility for the U87WT is not
diffusion, or that the diffusion of the U87WT cells is an
order-of-magnitude larger in this system than has been
observed in any other system.
The next set of simulations, shown in Fig. 4, allowed vi to
be nonzero. The best ﬁt for the U87WT, with an error of 0.4,
was achieved when vi ¼ 0.021 cm/day, while for the
U87DEGFR, vi was essentially zero, with an error of 0.1. To
test whether the U87DEGFR invasion could be as strongly
biased as the U87WT, we ﬁxed vi to be 0.02 cm/day, and
optimized the other three parameters, as shown in column 2
of Fig. 4. The ﬁt was very poor, with an error of 2.5. This
suggests that the U87WT invasive cells have a signiﬁcantly
higher radial velocity bias than the U87DEGFR invasive cells.
While Figs. 3 and 4 show best ﬁts to the data, it is possible
to perturb the parameters and still achieve ﬁts of comparable
x2 error. We explored the model sensitivity to changes in the
parameters in two ways. The ﬁrst was a traditional method,
where one parameter was varied while the other three
parameters were kept ﬁxed at their optimal values found in
Fig. 4. If one of the parameters was unimportant, we would
expect a change in the parameter to have little effect on the
error. The results of this sensitivity analysis, shown in Fig. 5,
indicate that each parameter is important to the model.
The above sensitivity does not explore what happens
when combinations of parameters are varied together. For
instance, although the error increases signiﬁcantly when
we vary vi and keep fD, s, gg ﬁxed, increasing vi while
decreasing D the proper amount may still give a good ﬁt to
the experiment. In a second sensitivity analysis, we explored
this effect by varying one parameter and then optimizing the
other three parameters to minimize the error. The results are
shown in Fig. 6. From the ﬁgure, we see that if we set vi ¼
0.02 cm/day for the DEGFR cell line, there is no possible
choice for the other three parameters that give a good ﬁt to
the model. This analysis allows us to reﬁne the parameter
bounds from Parameter Estimation and Parameter Optimi-
zation, above, as shown in Table 1 using the range over
which x2 , 1. This analysis indicates that both vi and s are
almost surely greater for U87WT than for U87DEGFR.
Because x2 remains ,1 for over almost the entire range of
FIGURE 3 U87DEGFR can be well described by unbiased motility alone, while U87WT cannot. The mathematical model (line) with only unbiased motion
(vi ¼ 0) was optimized to ﬁt the experimental data (dots) for the two cell lines. Each column uses a different set of parameters, given at the top of the column.
The ﬁrst column is ﬁt to the U87DEGFR data and the second and third are ﬁt to the U87WT data. Note that in column 2, D is at the maximum value it can take
in the constrained optimization. Loosening the restrictions on D gave a better ﬁt to the data, as shown in column 3, but here D is 10 times larger than is
reasonable.
Math Model of Glioblastoma Invasion 361
Biophysical Journal 92(1) 356–365
D and g, we have not gained any new information about
these parameters.
DISCUSSION AND CONCLUSIONS
We have presented new experimental data of the expansion
and dispersion of Glioblastoma Multiforme tumor spheroids
growing in three dimensions. We developed a continuum
model that quantitatively ﬁts the experimental data. The model
differs from those used by Swanson et al. (27), because it
focuses entirely on the invasive cells. This model is general
and can be applied to any three-dimensional spheroid in-
vasion assay.
The model describes invasion using four parameters:
undirected motility, D; directed motility, vi; shed rate, s; and
proliferation rate, g. The biological meaning for these param-
eters is as follows. The unbiased motility, D is a measure for
how ‘‘actively motile’’ these cells are. If glioblastoma cells
are seeded on a two-dimensional substrate, they actively
move around, but in no particular direction. The magnitude
of D captures this phenomenon. The biased motility, vi, is
needed to account for the fact that for U87WT, the invasive
cells detect where the spheroid is and actively migrate away
from it. The biological mechanism for this is not known. It
may be due to chemotaxis toward nutrients or away from
spheroid waste products; or haptotaxis due to degradation of
the gel by matrix metalloproteases; or a realignment of the
gel by the cells as they move. The shed rate, s, is a measure of
how quickly the cells leave the spheroid. It may also be
viewed as the inverse of cell-cell adhesion. The stronger the
cell-cell adhesion, the fewer invasive cells will be shed and
the smaller s will be. The proliferation rate, g, is a measure of
how fast the invasive cells increase in number once they are
shed from the spheroid; this term is the net increase, so it
includes loss of cells due to apoptosis. We chose these four
parameters to describe invasion because this was the simplest
model we could develop to quantitatively match the
experimental data. This choice illustrates that the most
impacting phenomena for describing invasion in this exper-
iment are undirected motility, directed motility, shedding
(or cell-cell adhesion), and proliferation.
Our models indicate that the difference in growth between
the wild-type and the DEGFR cell lines is a result of a strong
radially biased invasion of U87WT and a larger shedding
FIGURE 4 A signiﬁcant radial velocity bias is required to ﬁt the U87WT with a reasonable set of parameters, as shown in column 3. The mathematical
model (line) was optimized to ﬁt the experimental data (dots) for the two cell lines. Each column uses a different set of parameters, given at the top of the
column. Column 1 shows the best ﬁt to the U87DEGFR data. Notice that in column 1, vi¼ 0.001 cm/day, which is quite small. Column 2 shows the result when
we ﬁx vi¼ 0.02 cm/day to be as large as it is for U87WT, and then optimize the other parameters to achieve the best ﬁt. We see that the model cannot ﬁt the data
and that U87DEGFR cannot have an equally large velocity bias.
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rate (or smaller cell-cell adhesion) when compared to the
U87DEGFR. This distinction in invasion between the two
cell lines could result from alterations in the expression of
cell surface receptors caused by the mutant EGF receptor in
U87DEGFR.
This model can be extended in a variety of ways. To
explore the cause of the directional bias we could add
chemoattractants (36) or chemorepellants (37). The challenge,
however, would be to verify the model by measuring various
chemical concentrations in experiment. We could also
attempt to describe why the U87WT core shrinks at day
1 while the U87DEGFR does not, by introducing a second
partial differential equation for describing the cells in the
core (see also (24)). This model assumes radial symmetry,
and thus it does not capture the tenuous branches formed by
the U87DEGFR cells (see Fig. 1). Such branching is
FIGURE 5 Sensitivity Analysis 1. In each plot, one
parameter is varied while the other three remain ﬁxed at
their optimal values from Fig. 4. Notice that the model is
sensitive to all four parameters. The horizontal line
indicates where x2 ¼ 1. Below this line, the ﬁt to the
data is considered good.
FIGURE 6 Sensitivity Analysis 2. In each plot, one
parameter is ﬁxed at different values while the other three
are optimized to minimize error. This analysis is used to
generate revised estimates of the original parameter
bounds, shown in Table 1. Notice that the shed rate and
velocity bias for the U87WT cell line were signiﬁcantly
higher than for the U87DEGFR. The horizontal line
indicates where x2 ¼ 1. Below this line, the ﬁt to the
data is considered good.
Math Model of Glioblastoma Invasion 363
Biophysical Journal 92(1) 356–365
addressed in Khain and Sander (25). While we indirectly
model cell-cell adhesion at the core via the shed rate, we
neglect any cell-cell adhesion in the invasive zone. Some
models account for cell-cell adhesion in the tumor core
through surface tension (38,39), but while this is appropriate
where the cells are densely populated, it does not readily
extend to the sparsely populated invasive zone. Thus to
model cell-cell adhesion in the invasive zone, we believe a
discrete model (16,17,23,40) would be most suitable.
That the U87WT spheroids were more invasive than those
transfected with the mutant EGFR was unanticipated, since
EGFR activity has long been implicated in increased
malignancy of many cancers including glial cell tumors
(41,42). When examined in two-dimensional radial migra-
tion assays, the opposite effects were observed: U87DEGFR
exhibited a higher dispersion rate than U87WT (data not
shown), a ﬁnding that points toward the inﬂuences of the
extracellular matrix environment on cell phenotype and
behavior (43). It has been shown that in most glioblastoma
cell lines, EGFR ampliﬁcation is lost when the cells are
maintained in culture (44). We postulate that overexpression
of DEGFR does not compensate for the loss of EGFR
ampliﬁcation, and therefore results in decreased invasion in
the U87DEGFR spheroids in three dimensions. Despite this
effect, we still see a dramatic difference in the phenotypes of
the two cell lines: the U87WT invasive cells are shed faster
and move in a more directed fashion. Both these effects may
be the result of higher cell-cell adhesion in the U87DEGFR
cells. Although the results of the in vitro experiments cannot
directly be extrapolated to describe cell behavior in vivo, the
experiments are valuable in that they allow us to test and
develop novel hypotheses regarding a speciﬁc biological
process: cell invasion in a three-dimensional matrix.
We hypothesize that the U87WT cells bind more strongly
to the collagen-I than the U87DEGFR cells. If this were the
case, then it would be easier for the WT cells to break cell-
cell adhesion bonds and invade the matrix. Moreover, the
WT cells would be better able to reshape the collagen matrix,
forming directed highways in the matrix—and these high-
ways could lead to increased directed motility.
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